Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.910
-0.030 (-1.55%)
Mar 31, 2025, 9:51 AM EDT - Market open
Innate Pharma Employees
Innate Pharma had 179 employees as of December 31, 2023. The number of employees decreased by 32 or -15.17% compared to the previous year.
Employees
179
Change (1Y)
-32
Growth (1Y)
-15.17%
Revenue / Employee
$116,376
Profits / Employee
-$286,131
Market Cap
169.04M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IPHA News
- 3 days ago - Innate Pharma S.A. (IPHA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Innate Pharma Reports Full Year 2024 Financial Results and Business Update - Business Wire
- 5 days ago - Innate Pharma Highlights Antibody Drug Conjugate IPH4502 Abstract Selected for the AACR 2025 Annual Meeting - Business Wire
- 6 days ago - Innate Pharma announces its participation in the Life Sciences Van Lanschot Kempen Conference - Business Wire
- 10 days ago - Innate Pharma: Moving Into The Padcev Space - Seeking Alpha
- 11 days ago - Innate Pharma Announces Conference Call and Webcast for Full Year 2024 Financial Results - Business Wire
- 4 weeks ago - Innate Pharma to Participate in the 2025 Leerink Partners Global Healthcare Conference - Business Wire
- 5 weeks ago - Innate: Lacutamab Treatment Program Moves Forward With Potential Expansion - Seeking Alpha